Correspondence
Fatal Aspergillosis in a Patient with SARS Who Was Treated with Corticosteroids
N Engl J Med 2003; 349:507-508July 31, 2003
- Article
To the Editor:
We report the case of a patient with severe acute respiratory syndrome (SARS) who died of aspergillosis after prolonged treatment with corticosteroids. The patient was a 39-year-old male physician based at the intensive-care unit of a small hospital in Guangzhou, China; he had no concurrent medical illness. Many patients with SARS were admitted to the hospital where he worked during the eight weeks before April 4, 2003, when he presented with a sore throat and a low-grade fever (37.3°C). Five days later, he had a high fever (38.5°C) and a low leukocyte count (3.4 ×109 per liter; 63.6 percent neutrophils and 26.2 percent lymphocytes), and he was admitted to the hospital with suspected SARS.
The patient was treated with twice-daily methylprednisolone (80 mg in the morning and 40 mg in the evening) for two days; the dose was decreased to 20 mg twice daily as the fever subsided, on April 12. The fever recurred on April 14, and chest radiography showed an infiltrate in the left lower lobe; the leukocyte count was 13.5×109 per liter (94.0 percent neutrophils and 6.0 percent lymphocytes). Methylprednisolone was given again (20 mg in the morning and 80 mg in the evening), and the patient was transferred to a larger hospital on April 15. Intravenous methylprednisolone therapy (80 mg twice daily) was then administered. The patient's clinical condition improved; he had no fever and could walk without dyspnea. The infiltrate in the left lung diminished in density, and the dose of methylprednisolone was reduced to 40 mg twice daily on April 19.
On April 29, the patient was again dyspneic, and radiographs showed a left basilar infiltrate. Bone marrow aspiration revealed suppression of all three cell lineages. On May 4, the patient was transferred to a university teaching hospital. Methylprednisolone (240 mg twice daily) was given, but the next day the oxygen saturation fell to 60 percent, and endotracheal intubation was performed to allow mechanical ventilation. The patient showed signs that were consistent with the presence of tentorial herniation; his pupils were fixed and dilated. Computed tomographic examination of the cranium showed diffuse cerebral edema with localized hemorrhage. Enzyme-linked immunosorbent assay and indirect immunofluorescence established the presence of specific antibodies against a SARS-associated virus in the serum. The fungal culture of sputum obtained on April 14 was negative; the bacterial cultures of sputum obtained on May 2 and May 4 were negative as well. Despite massive supportive care, the patient died on May 7.
Autopsy showed SARS-associated pathologic changes,1,2 including consolidation, hemorrhage, and edema of the lungs; proliferation and desquamation of alveolar epithelial cells; exudation of monocytes, lymphocytes, and plasma cells in alveoli; and formation of hyaline membranes. In addition, there were multiple lung abscesses containing aspergillus (Figure 1Figure 1
Specimens of the Lung.). There was also cerebral edema, diffuse cerebral hemorrhage, aspergillus meningitis, and multiple brain abscesses containing aspergillus. Multiple abscesses containing aspergillus were also found in the heart, liver, kidney, spleen, stomach, pancreas, and adrenal glands.In this patient, it is likely that SARS infection induced mild immunosuppression3 and that immune function was further suppressed by high-dose corticosteroid treatment. At this time, it has not been established whether corticosteroid treatment has an effect on SARS-associated mortality,4 although it may decrease clinical morbidity.5 We speculate that use of corticosteroids over the course of many weeks led to the serious secondary aspergillus infection that contributed to the death of this patient. We urge caution and restraint in the use of corticosteroids in the treatment of SARS.
5 ReferencesHuijun Wang, M.D.
Yanqing Ding, M.D.
Xin Li, M.D.
Lei Yang, M.D.
Wenli Zhang, M.D.
Wei Kang, M.D.
First Military Medical University, Guangzhou 510515, People's Republic of China
hjwang@fimmu.com 1
Ding Y, Wang H, Shen H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol (in press).
2
Nicholls JM ,Poon LM ,Lee KC , et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003;361:1773-1778
CrossRef | Web of Science | Medline3
Panesar NS . Lymphopenia in SARS. Lancet 2003;361:1985-1985
CrossRef | Web of Science | Medline4
Oba Y . The use of corticosteroids in SARS. N Engl J Med 2003;348:2034-2035
Full Text | Web of Science | Medline5
Lee N ,Hui D ,Wu A , et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-1994
Full Text | Web of Science | Medline
- Citing Articles (33)
Citing Articles
1
Yuejie Zheng, Yanxia He, Jikui Deng, Zhiwei Lu, Jurong Wei, Weiguo Yang, Zhengzhen Tang, Boning Li, Jaosheng Zhang, Li Wang, Hui Zhao, Xiaonan Li, Zhenzhu Yu, Ping Song, Yijiao Ma, Yingfei Li, Chengrong Li. (2011) Hospitalized children with 2009 influenza a (H1N1) infection in Shenzhen, China, november-december 2009. Pediatric Pulmonology 46:3, 246-252
CrossRef2
David S.C. Hui, Paul K.S. Chan. (2010) Severe Acute Respiratory Syndrome and Coronavirus. Infectious Disease Clinics of North America 24:3, 619-638
CrossRef3
Xiaoping Zhang, Jingxue Wang, Kun Wen, Zhirong Mou, Liyun Zou, Xiaoyan Che, Bing Ni, Yuzhang Wu. (2009) Antibody Binding Site Mapping of SARS-CoV Spike Protein Receptor-Binding Domain by a Combination of Yeast Surface Display and Phage Peptide Library Screening. Viral Immunology 22:6, 407-415
CrossRef4
S. S. Y. Wong, K.-Y. Yuen. (2008) The management of coronavirus infections with particular reference to SARS. Journal of Antimicrobial Chemotherapy 62:3, 437-441
CrossRef5
David S.C. HUI. (2008) Influenza A/H5N1 infection: Other treatment options and issues. Respirology 13:s1, S22-S26
CrossRef6
G.-p. Zhao. (2007) SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era. Philosophical Transactions of the Royal Society B: Biological Sciences 362:1482, 1063-1081
CrossRef7
Loretta Yin-Chun Yam, Arthur Chun-Wing Lau, Florence Yuk-Lin Lai, Edwina Shung, Jane Chan, Vivian Wong. (2007) Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong. Journal of Infection 54:1, 28-39
CrossRef8
L He, Y Ding, Q Zhang, X Che, Y He, H Shen, H Wang, Z Li, L Zhao, J Geng, Y Deng, L Yang, J Li, J Cai, L Qiu, K Wen, X Xu, S Jiang. (2006) Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2 + cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. The Journal of Pathology 210:3, 288-297
CrossRef9
Cai Qi, Jin-Zhu Duan, Zhan-Hui Wang, Yan-Yan Chen, Pan-He Zhang, Lin Zhan, Xi-Yun Yan, Wu-Chun Cao, Gang Jin. (2006) Investigation of interaction between two neutralizing monoclonal antibodies and SARS virus using biosensor based on imaging ellipsometry. Biomedical Microdevices 8:3, 247-253
CrossRef10
D.N. Singh, N. Verma, S. Raghuwanshi, P.K. Shukla, D.K. Kulshreshtha. (2006) Antifungal anthraquinones from Saprosma fragrans. Bioorganic & Medicinal Chemistry Letters 16:17, 4512-4514
CrossRef11
Nirmal S. Panesar. (2006) Glucocorticoid treatment of patients with SARS: implications for mechanisms of immunopathology. Nature Reviews Immunology 6:4, 334-334
CrossRef12
Christopher P. Johnson, Charles E. Edmiston, Yong-Ran Zhu, Mark B. Adams, Allan M. Roza, Viswanath Kurup. (2005) A Murine Model of Invasive Aspergillosis: Variable Benefit of Interferon-Gamma Administration under In Vitro and In Vivo Conditions. Surgical Infections 6:4, 397-407
CrossRef13
Gary W. K. Wong, David S. C. Hui. (2005) Current Understanding of Severe Acute Respiratory Syndrome (SARS). Clinical Pulmonary Medicine 12:6, 337-340
CrossRef14
J. Xu, S. Zhong, J. Liu, L. Li, Y. Li, X. Wu, Z. Li, P. Deng, J. Zhang, N. Zhong, Y. Ding, Y. Jiang. (2005) Detection of Severe Acute Respiratory Syndrome Coronavirus in the Brain: Potential Role of the Chemokine Mig in Pathogenesis. Clinical Infectious Diseases 41:8, 1089-1096
CrossRef15
S. T. Lai. (2005) Treatment of severe acute respiratory syndrome. European Journal of Clinical Microbiology & Infectious Diseases 24:9, 583-591
CrossRef16
Bojian Zheng, Kai-Yuan Cao, Cangel P.Y. Chan, Junet W.Y. Choi, Wingman Leung, Manfai Leung, Zhao-Hui Duan, Yang Gao, Ming Wang, Biao Di, Jörg M. Hollidt, Andreas Bergmann, Matthias Lehmann, Ilka Renneberg, John S.L. Tam, Paul K.S. Chan, George W.H. Cautherley, Dietmar Fuchs, Reinhard Renneberg. (2005) Serum neopterin for early assessment of severity of severe acute respiratory syndrome. Clinical Immunology 116:1, 18-26
CrossRef17
David A Groneberg, Susan M Poutanen, Donald E Low, Hartmut Lode, Tobias Welte, Peter Zabel. (2005) Treatment and vaccines for severe acute respiratory syndrome. The Lancet Infectious Diseases 5:3, 147-155
CrossRef18
Danuta M. Skowronski, Caroline Astell, Robert C. Brunham, Donald E. Low, Martin Petric, Rachel L. Roper, Pierre J. Talbot, Theresa Tam, Lorne Babiuk. (2005) Severe Acute Respiratory Syndrome (SARS): A Year in Review. Annual Review of Medicine 56:1, 357-381
CrossRef19
Frederick G Hayden, Mark R Denison. 2005. Antiviral Agents for SARS. , 184-202.
CrossRef20
F. S. Wang, F. L. Chu, L. Jin, Y. G. Li, Z. Zhang, D. Xu, M. Shi, H. Wu, J.-M. Moulds. (2005) Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome. Clinical and Experimental Immunology 139:1, 112-119
CrossRef21
Samson SY. Wong, KY Yuen. (2005) The severe acute respiratory syndrome (SARS). Journal of Neurovirology 11:5, 455-468
CrossRef22
David M Hwang, Dean W Chamberlain, Susan M Poutanen, Donald E Low, Sylvia L Asa, Jagdish Butany. (2005) Pulmonary pathology of severe acute respiratory syndrome in Toronto. Modern Pathology 18:1, 1-10
CrossRef23
Jianping Liu, Eric Manheimer, Yi Shi, Christian Gluud. (2004) Chinese Herbal Medicine for Severe Acute Respiratory Syndrome: A Systematic Review and Meta-Analysis. The Journal of Alternative and Complementary Medicine 10:6, 1041-1051
CrossRef24
C.W. Leung, W.K. Chiu. (2004) Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children. Paediatric Respiratory Reviews 5:4, 275-288
CrossRef25
Yuxian He, Yusen Zhou, Pamela Siddiqui, Shibo Jiang. (2004) Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry. Biochemical and Biophysical Research Communications 325:2, 445-452
CrossRef26
Nelson Lee, K.C. Allen Chan, David S. Hui, Enders K.O. Ng, Alan Wu, Rossa W.K. Chiu, Vincent W.S. Wong, Paul K.S. Chan, K.T. Wong, Eric Wong, C.S. Cockram, John S. Tam, Joseph J.Y. Sung, Y.M. Dennis Lo. (2004) Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. Journal of Clinical Virology 31:4, 304-309
CrossRef27
Yuxian He, Yusen Zhou, Shuwen Liu, Zhihua Kou, Wenhui Li, Michael Farzan, Shibo Jiang. (2004) Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochemical and Biophysical Research Communications 324:2, 773-781
CrossRef28
Paul A Tambyah. (2004) Severe acute respiratory syndrome from the trenches, at a Singapore university hospital. The Lancet Infectious Diseases 4:11, 690-696
CrossRef29
D. G. Maki. (2004) SARS Revisited: The Challenge of Controlling Emerging Infectious Diseases at the Local, Regional, Federal, and Global Levels. Mayo Clinic Proceedings 79:11, 1359-1366
CrossRef30
David SC Hui, Gary WK Wong. (2004) Advancements in the battle against severe acute respiratory syndrome. Expert Opinion on Pharmacotherapy 5:8, 1687-1693
CrossRef31
M. D. Christian, S. M. Poutanen, M. R. Loutfy, M. P. Muller, D. E. Low. (2004) Severe Acute Respiratory Syndrome. Clinical Infectious Diseases 38:10, 1420-1427
CrossRef32
Kenneth TSANG, Nan Shan ZHONG. (2003) SARS: pharmacotherapy. Respirology 8:s1, S25-S30
CrossRef33
D.A. Groneberg. (2003) Severe acute respiratory syndrome: global initiatives for disease diagnosis. QJM 96:11, 845-852
CrossRef
